Virinchi Hospital successfully performs heart valve “replacement” on a 74-year-old, using a novel implant!
Indigenously developed implant – HYDRA Aortic Valve has multiple advantages…
- It’s flexible & enables doctors to easily deploy in aging rigid blood vessels…
- It’s retractable, enables correction of less than ideal “replacement“…
- The new implant presents a distinct cost advantage…
- Used for the first time in Hyderabad…
A very sophisticated yet short duration heart valve implant procedure was successfully performed on a 74-year-old lady Mrs. S.L. from Vikarabad. She was suffering from severe Aortic valve stenosis. And she was admitted at the Virinchi Hospital in Hyderabad.
The procedure was performed five days ago by Dr Saratchandra, Senior Consultant Cardiologist, Virinchi Hospital, using the novel HYDRA Aortic Valve. This procedure performed and it was successful and for the first time in Hyderabad. The 74 year old lady patient recovered well and she was discharged from the hospital today.
The Aortic Valve has the critical function of letting blood flow from heart to other parts of the body.
The indigenously developed heart valve implant – HYDRA Aortic Valve, has multiple benefits. And was recently approved for patient usage. The device is flexible, hence can seamlessly track along tortuous and stiff vessels, especially for old age patients.
Trans Aortic Valve Replacement (TAVR), which uses this implant, is usually performed on old age patients, whose arteries used to be rigid and tortuous. The implant is retractable, a salient feature, considering the opportunity to appropriately redeploy in instances of less than ideal replacement.
What Virinchi Hospital Claims (Continued)
The surgery is priced half of that of imported devices and will be a great relief for Indian patients. Patients, who struggle to meet the higher medical costs have some respite. The device is gaining tremendous popularity abroad too, due to its advanced technology and low cost advantage. It has already been given the CE mark and is being used in European countries.
“This new device is both medical fraternity and patient friendly, has several advanced features making it the prime option for TAVR. Being Indian made and less expensive are amongst the innumerable advantages it presents”. says Dr Saratchandra.
The 74 year old patient, Mrs. S.L. had a prior history of heart attack four months ago. She underwent an emergency angioplasty at Virinchi Hospital and recovered well from it. However, she was also diagnosed as having Aortic valve stenosis due to severe narrowing of the valve, with corresponding symptoms and was advised to undergo TAVR procedure, 3 months later.
Explaining her condition, Dr Saratchandra said: “This is a critical heart condition in which one of the main valves of the heart that helps maintain the unidirectional flow of the blood to the body, becomes stiff. And hampers functioning in full capacity. If left untreated this condition can result in recurrent loss of consciousness, heart failure, stroke and sudden death.”
High Quality Treatment at Virinchi Hospital & More…
Considering the variables, the team at Virinchi Hospital quickly decided to adapt the more novel procedure of Transcatheter Aortic Valve Replacement (TAVR). Virinchi Hospital houses one of the latest high-end flat panel catheter laboratory (Cath-lab in short). And the technology enables the team to successfully implant the newly launched HYDRA Valve to the patients.
The procedure was planned and done by a team led by Dr Saratchandra and included Interventional Cardiologists. Dr. Deepak Saha and Dr Sumeet Sinha, Dr. Avinash Dal, Cardiac Surgeon and Dr. Muralidhar Joshi, HOD (Anesthesia), along with the entire ‘Heart Team’ of the Hospital. This procedure is the first HYDRA Valve implant in Hyderabad.
Until a few years ago there were only two companies globally, who were manufacturing TAVR implants. However, with estimates of over a significant percentage of heart patients in the Indian population. They require an aortic valve implant.
India based medical device companies like SMT (Sahajanand Medical Technologies) are on the forefront of such cutting edge and outcome based medical device manufacturing. With over a million patient implants, SMT is a trusted name for manufacturing drug eluting coronary stents for over 20 years now.
Medical Science Advancement…
HYDRA is one of the latest implants and is approved by regulatory bodies of India, DCGI and it’s also CE approved for use in Europe. Hydra comes with the complete clinical benefits of an internationally produced implant along with the cost advantage to the Indian population.
At Virinchi Hospital, we are continuously trying to maintain standards in medical care for our patients. We will continue to provide world class services and facilities while keeping a keen eye on evidence- based medicine”. Added Dr Saratchandra.
